期刊文献+

动态监测降钙素原对脑出血患者感染及预后判断的意义 被引量:4

Clinical significance of dynamic determination of serum procalcitonin levels in judgement of infection and prognosis in patients with brain hemorrhage
下载PDF
导出
摘要 目的:探讨动态监测血清降钙素原(PCT)对脑出血患者感染及预后判断的临床意义。方法:对入住重症监护病房的重度脑出血患者42例在入院第1、2、3、5、7天分别采集静脉血标本检测血清PCT值,以判断PCT水平变化与脑出血患者感染及预后之间的关系。结果:合并感染组与非感染组相比各时段血清PCT明显升高,差异有显著性(P<0.01)。以入院第10天为界将合并感染患者分为存活组与死亡组,其中存活组与死亡组各时段PCT水平比较存在统计学差异。结论:动态监测血清PCT的水平变化可以作为判断脑出血患者感染及预后的有效指标之一。 Objective To explore the clinical significance of dynamic determination of serum procalcitonin (PCT) levels in judgement of infection and prognosis in patients with brain hemorrhage. Methods Serum PCT levels were deteeted in 42 patients with severe brain hemorrhage on the first, second, third, fifth, and seventh day of admission in intensive care unit. The association of the changes of PCT and infection in the patients and their prognosis was analyzed. Results Serum PCT levels in the concurrent infection group were significantly higher than those in the non-infection group at different time points(P 〈 0.01 ). The patients with concurrent infection were subdivided into survival group and death group on the tenth day. PCT levels at different time points differed significantly between the two subgroups. Conclusions The alteration of serum PCT level may be used as one of the effective predictors for infection in patients with brain hemorrhage and for their prognosis.
出处 《实用医学杂志》 CAS 2008年第20期3497-3499,共3页 The Journal of Practical Medicine
基金 南京市医学重点科技发展项目(编号:YKK05068)
关键词 脑出血 感染 预后 降钙素原 Cerebral hemorrhage Infection Prognosis Procalcitonin
  • 相关文献

参考文献10

  • 1Carlet J. Rapid diagnostic methods in the detection of sepsis [J]. Infect Dis Clin North Am, 1999,13(2) :483-494.
  • 2Snider R H, Nylen E S, Becker K L. Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization [J]. J Investig Med, 1997,45(9) :552-560.
  • 3Dandona P, Nix D, Wilson M F, et al. Procalcitonin increase after endotoxin injection in normal subjects [J]. J Clin Endocrinol Metab, 1994,79(9) : 1605-1608.
  • 4姚咏明,盛志勇,林洪远,柴家科.脓毒症定义及诊断的新认识[J].中国危重病急救医学,2004,16(6):321-324. 被引量:307
  • 5Levy M M,Fink M P,Marshall J C,et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference [J ]. Crit Care Med,2003 ,31(5) : 1250-1256.
  • 6Balcli C, Sungurtekin H, Gurses E, et al.Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit [J]. Crit Care, 2003,7 ( 1 ) : 85-90.
  • 7van Rossum A M, Wulkan R W, Qudesluys-Murphy AM, et al. Procalcitonin as an early marker of infection in neonates and children [ J ]. Lancet Infect Dis, 2004, 4 (10) : 620-630.
  • 8Briel M, Christ-Crain M, Young J, et al. Procalcitonin-guided antibiotic use versus a standard approach for acute respiratory tract infections in primary care : study protocol for a randomised controlled trial and baseline characteristics of participating general practitioners [J]. BMC Fam Pract,2005,6:34.
  • 9Nylen E S, Whang K T, Sinider T H, et al. Mortality is in creased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experinmental sepsis [J]. Crit Care Med,1998,26 (6):1001- 1006.
  • 10Masia M, Gutierrez F, Conrado Shum, et al. Uesfulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index [J]. Chest, 2005,128 (4) : 2223-2229.

共引文献306

同被引文献29

  • 1吴健,李澎.血清降钙素原对危重症患者多器官功能障碍综合征的预测价值[J].中国全科医学,2007,10(12):965-966. 被引量:8
  • 2赵玉玲.降钙素原对脓毒症早期诊断的临床意义[J].检验医学,2006,21(4):431-431. 被引量:37
  • 3左震华,蔡少华,李洪霞,刘长庭,俞森洋.降钙素原对呼吸机相关性肺炎诊断及预后判断的临床意义[J].中华医院感染学杂志,2006,16(12):1353-1355. 被引量:34
  • 4周国花 蔡文训 罗华.降钙素原的临床应用研究进展.河北医科大学学报,2009,30(12):1351-1354.
  • 5张代民.降钙素原的测定与临床应用进展[J].实用医药杂志,2007,24(5):619-622. 被引量:57
  • 6Simon L, Gauvin F, Amre DK, et al. Serum procalcito- nin and C-reactive protein levels as markers of bacte- rial infection a systematic review and meta-analysis [J ]. Clinical Infectious Diseases, 2004, 39 (2) : 206- 210.
  • 7Giamarellos-Bourboulis EJ, Mega A, Grecka P, et al. Procalcitonin: a marker to clearly differentiate sys- temic inflammatory response syndrome and sepsis in the critically ill patient[J]. Intensive Care Medicine, 2002,28(9) : 1351-1356.
  • 8Levy MM,F ink MP,Marshall JC. 2001Scn/ESKM/ACCP/ATS/SIS intemational sepsis definitions conference[J].CRITICAL CARE MEDICINE,2003,(04):1250-1256.
  • 9Claeys R,Vinken S,Spapen H. Plasma procalcitonin and C-reactive protein in acute septic shock:clinical and biological correlates[J].CRITICAL CARE MEDICINE,2002,(04):757-762.
  • 10Ghorbani G. Procalciton in role in differential diagnosis of infection stages and non infection inflammation[J].Pak J Biol Sa,2009,(04):393-396.

引证文献4

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部